RJ Lee Group’s Pharmaceutical and Biotechnical Services group will have a table top exhibit at the 21st Annual CED Life Science Conference in Raleigh, N.C. The exhibit will introduce the newly launched Visual Inspection Particle Standards (VIPs) and highlight the recently published Pharmaceutical Manufacturing Magazine article “Characterizing Foreign Particulate Matter: Using Forensics in QbD,” written by RJ Lee Group scientists.
This two-day conference includes world-class speakers, a variety of panels on industry topics and trends, and networking opportunities with life science leaders. It is hosted by CED in partnership with the North Carolina Biotechnology Center and NC Biosciences Organization (NCBIO) to identify, enable and promote high-growth, high-impact companies and to accelerate the entrepreneurial culture of the Research Triangle and North Carolina. Mr. Christopher Viehbacher, CEO of Sanofi, will be the opening keynote speaker and panelists include top executives from Johnson & Johnson, Medtronic, and Bristol-Myers Squibb.
CED is a private, non-profit organization that provides the entrepreneurial community in the Research Triangle Park region with the necessary tools, connections and resources to start something new. CED’s extensive range of initiatives from personal consultations and mentoring to educational programs and conferences empower entrepreneurs to transform ideas into businesses and to take existing businesses to the next level. It is the southeast’s largest entrepreneurial support organization.
About NC Biotechnology Center
The Biotechnology Center is a private, non-profit corporation supported by the North Carolina General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.